Accent Capital Management, LLC Astrazeneca PLC Transaction History
Accent Capital Management, LLC
- $163 Billion
- Q2 2024
A detailed history of Accent Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Accent Capital Management, LLC holds 1,241 shares of AZN stock, worth $105,646. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,241
Previous 1,115
11.3%
Holding current value
$105,646
Previous $75.5 Million
28.12%
% of portfolio
0.06%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,330Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.53 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.63 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.45 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.12 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.5 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $264B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...